Suppr超能文献

门静脉切除在胆管癌和胰腺癌中的手术指征及意义

Surgical indication and significance of portal vein resection in biliary and pancreatic cancer.

作者信息

Tashiro S, Uchino R, Hiraoka T, Tsuji T, Kawamoto S, Saitoh N, Yamasaki K, Miyauchi Y

机构信息

First Department of Surgery, Kumamoto University Medical School, Japan.

出版信息

Surgery. 1991 Apr;109(4):481-7.

PMID:1848949
Abstract

Tumor and vascular resection was carried out in 27 patients with biliary and pancreatic cancer. Vascular resection included resection and reconstruction of the both the portal vein and hepatic artery in two of the patients. Portal vein resection only was carried out in 23 patients, and resection of the side wall and plasty of the portal vein was carried out in the other two patients. The technical limit of portal vein resection without graft was 4 cm in the hepatic hilus and 7 cm after total pancreatectomy or pancreatoduodenectomy without grafts. On temporary occlusion of the portal vein between resection and reconstruction, simple occlusion was sufficient if it occurred within 30 minutes. In occlusion of more than 30 minutes, simultaneous occlusion of the superior mesenteric artery is better to prevent congestion of the intestine. If occlusion of more than 60 minutes is anticipated, a bypass between the superior mesenteric vein and the femoral vein with Anthron tube is recommended. The postoperative course was uneventful in 20 of the 27 patients. Two patients died within 1 month after surgery. The mortality rate for this aggressive surgery was 8.4%. Minor complications such as hydrothorax, small bile leakage, and localized abscess were observed but soon subsided in five patients. Fourteen of 27 patients survived or are alive after more than 1 year, and 9 of 14 patients survived or are alive after 2 years. Forty-seven percent of the patients who had no lymph node metastasis or peritumor lymph node metastasis without cancerous invasion of the portal vein intima survived more than 2 years. The longest length of survival of a patient with nonfunctioning islet cell carcinoma of the pancreatic head was 5 years 9 months. The longest surviving patient with ductal cell carcinoma of the pancreas is still living after 4 years. This approach is recommended in certain patients with vascular involvement but without lymph node metastasis or those patients with only peritumor lymph node involvement. Frozen section of mesenteric and paraaortic nodes should be standard practice before this aggressive resection.

摘要

对27例胆管癌和胰腺癌患者进行了肿瘤及血管切除术。血管切除包括2例患者的门静脉和肝动脉切除及重建。仅门静脉切除在23例患者中进行,另外2例患者进行了门静脉侧壁切除及修补。无移植门静脉切除的技术极限在肝门处为4 cm,全胰切除或胰十二指肠切除术后无移植时为7 cm。在切除与重建之间临时阻断门静脉时,如果阻断时间在30分钟以内,单纯阻断即可。阻断时间超过30分钟时,同时阻断肠系膜上动脉可更好地预防肠道充血。如果预计阻断时间超过60分钟,建议用Anthron管在肠系膜上静脉和股静脉之间建立旁路。27例患者中有20例术后病程平稳。2例患者术后1个月内死亡。这种激进手术的死亡率为8.4%。观察到5例患者出现少量并发症,如胸腔积液、小胆漏和局部脓肿,但很快消退。27例患者中有14例存活或术后1年以上仍存活,14例患者中有9例存活或术后2年以上仍存活。门静脉内膜无癌侵犯且无淋巴结转移或肿瘤周围淋巴结转移的患者中,47%存活超过2年。胰头无功能胰岛细胞癌患者最长存活时间为5年9个月。胰腺导管细胞癌最长存活患者术后4年仍在世。对于某些有血管受累但无淋巴结转移或仅肿瘤周围淋巴结受累的患者,推荐采用这种方法。在进行这种激进切除之前,肠系膜和腹主动脉旁淋巴结的冰冻切片应作为标准操作。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验